(Q53050714)

10 May 2018

title

Efficacy of rivastigmine transdermal patch on activities of daily living: item responder analyses. (English)

1 reference

10 May 2018

3

Frederick A Schmitt

1 reference

10 May 2018

author name string

Gustavo Alva

1

1 reference

10 May 2018

George T Grossberg

2

1 reference

10 May 2018

Xiangyi Meng

4

1 reference

10 May 2018

Jason T Olin

5

1 reference

10 May 2018

language of work or name

English

0 references

publication date

1 April 2011

1 reference

10 May 2018

International Journal of Geriatric Psychiatry

published in

1 reference

10 May 2018

volume

26

1 reference

10 May 2018

issue

4

1 reference

10 May 2018

page(s)

356-363

1 reference

10 May 2018

Ability to perform activities of daily living is the main factor affecting quality of life in patients with dementia

cites work

1 reference

Disability and cognitive impairment in the elderly

21 January 2018

1 reference

Assessing and predicting functional impairment in Alzheimer's disease: the emerging role of frontal system dysfunction

21 January 2018

1 reference

Impact of chronic systemic and neurological disorders on disability, depression and life satisfaction.

21 January 2018

1 reference

Executive dyscontrol in dementia, with emphasis on subcortical pathology and the role of butyrylcholinesterase

21 January 2018

1 reference

The effects of donepezil in Alzheimer's disease - results from a multinational trial.

21 January 2018

1 reference

A rivastigmine patch for the treatment of Alzheimer's disease and Parkinson's disease dementia

21 January 2018

1 reference

The impact of caregiver executive skills on reports of patient functioning

21 January 2018

1 reference

Activities of daily living in patients with dementia: clinical relevance, methods of assessment and effects of treatment

21 January 2018

1 reference

Cognitive impairment as a strong predictor of incident disability in specific ADL-IADL tasks among community-dwelling elders: the Azuchi Study

21 January 2018

1 reference

Rivastigmine for dementia associated with Parkinson's disease

21 January 2018

1 reference

Activities of daily living in moderate-to-severe Alzheimer disease: an analysis of the treatment effects of memantine in patients receiving stable donepezil treatment.

21 January 2018

1 reference

Predicting time to nursing home placement based on activities of daily living scores--a modelling analysis using data on Alzheimer's disease patients receiving rivastigmine or donepezil

21 January 2018

1 reference

Functional impairment, healthcare costs and the prevalence of institutionalisation in patients with Alzheimer's disease and other dementias.

21 January 2018

1 reference

Predicting caregiver burden from daily functional abilities of patients with mild dementia

21 January 2018

1 reference

Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial

21 January 2018

1 reference

Executive cognitive impairment: a novel perspective on dementia

21 January 2018

1 reference

Executive dysfunction in Alzheimer disease

21 January 2018

1 reference

A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group.

21 January 2018

1 reference

Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline

21 January 2018

1 reference

Cost-effectiveness of memantine in moderate-to-severe Alzheimer's disease patients receiving donepezil.

21 January 2018

1 reference

Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial. Galantamine International-1 Study Group

21 January 2018

1 reference

A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD.

21 January 2018

1 reference

IDEAL: a 6-month, double-blind, placebo-controlled study of the first skin patch for Alzheimer disease

21 January 2018

1 reference

A six-month double-blind, randomized, placebo-controlled study of a transdermal patch in Alzheimer's disease–– rivastigmine patchversus capsule

21 January 2018

1 reference

Functional disability in Alzheimer's disease.

21 January 2018

1 reference

7 January 2021

A new approach to the qualitative evaluation of functional disability in dementia

1 reference

7 January 2021

Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily Living

1 reference

7 January 2021

Patterns and predictors of institutionalization in community-based dementia patients

1 reference

7 January 2021

Identifiers

DOI

10.1002/GPS.2534

1 reference

10 May 2018

1 reference

10 May 2018